SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040058
Filing Date
2023-11-09
Accepted
2023-11-09 16:15:46
Documents
81
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1547801
2 ex3-1.htm EX-3.1 36632
3 ex31-1.htm EX-31.1 28632
4 ex32-1.htm EX-32.1 9783
  Complete submission text file 0001493152-23-040058.txt   8233305

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lctx-20230930.xsd EX-101.SCH 50843
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lctx-20230930_cal.xml EX-101.CAL 68309
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lctx-20230930_def.xml EX-101.DEF 192168
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lctx-20230930_lab.xml EX-101.LAB 398802
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lctx-20230930_pre.xml EX-101.PRE 315907
75 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1782704
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 231392662
SIC: 2836 Biological Products, (No Diagnostic Substances)